| National Psychiatry, Llc | |
|
6101 Pine Ridge Road Naples FL 34119 | |
| (239) 330-2933 | |
| Not Available |
| Full Name | National Psychiatry, Llc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 6101 Pine Ridge Road, Naples, Florida |
| Authorized Official Name and Position | Jonathan W. Marsh (OWNER) |
| Authorized Official Contact | 2393302933 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| National Psychiatry, Llc 2338 Immokalee Rd # 186 Naples FL 34110-1445 Ph: (239) 330-2933 | National Psychiatry, Llc 6101 Pine Ridge Road Naples FL 34119 Ph: (239) 330-2933 |
| NPI Number | 1225766793 |
|---|---|
| Provider Enumeration Date | 08/11/2022 |
| Last Update Date | 08/11/2022 |
| Certification Date | 07/19/2022 |
| Medicare PECOS PAC ID | 0648655241 |
|---|---|
| Medicare Enrollment ID | O20220919000822 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225766793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
| Provider Name | Majd Alsamman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1932112521 PECOS PAC ID: 1052396470 Enrollment ID: I20040621001114 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Provider Name | Richard J. Capiola |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1124146055 PECOS PAC ID: 7517983877 Enrollment ID: I20051017000753 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Provider Name | Pamela S Kain |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1588852701 PECOS PAC ID: 5193801470 Enrollment ID: I20080326000988 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Provider Name | Toni D Sanchez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588195754 PECOS PAC ID: 3476830332 Enrollment ID: I20170502000002 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Provider Name | Danielle J A Wilson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922683622 PECOS PAC ID: 9234531344 Enrollment ID: I20211006001549 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Provider Name | Watson Camilus |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750013157 PECOS PAC ID: 6608258520 Enrollment ID: I20220809000769 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Provider Name | Ryan Hughes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376262568 PECOS PAC ID: 9234515149 Enrollment ID: I20220929003422 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Provider Name | Elle Aime Jah Pierre |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558074237 PECOS PAC ID: 6507230588 Enrollment ID: I20230314001135 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
| Provider Name | Carlin Marcella Smart |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154001865 PECOS PAC ID: 9739543992 Enrollment ID: I20230907000653 |
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
News Archive
In today's headlines, reports about President Barack Obama's pick to succeed Donald Berwick as chief of the Centers for Medicare and Medicaid Services, as well as news about the Supreme Court's consideration of the health law and more on the nation's budget.
Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.
AVEO Pharmaceuticals, Inc. today announced that it has initiated patient enrollment in a multi-center Phase 2 exploratory biomarker study of tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC).
A new study by the American Enterprise Institute found that using brand-name drugs instead of generics may have added as much as $329 million in extra spending in 2009.
› Verified 1 days ago
Fresh Start Private Florida Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1415 Panther Ln, Naples, FL 34109 Phone: 239-591-6240 | |
Mindful Solutions Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4532 Tamiami Trl E Ste 302, Naples, FL 34112 Phone: 239-307-8038 | |
Psychotherapy Sw Fl Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 810 Anchor Rode Dr, Naples, FL 34103 Phone: 239-247-4231 | |
Little World Aba Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 708 Goodlette-frank Rd N Ste 326, Naples, FL 34102 Phone: 239-200-2405 | |
Dnt Institute Incorporated Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1750 Sw Health Pkwy, Naples, FL 34109 Phone: 239-566-7717 | |
Nami Of Collier County Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5020 Tamiami Trl N, Suite 110, Naples, FL 34103 Phone: 239-434-6726 | |
Behavioral Tender Care Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 300 5th Ave S Ste 203d, Naples, FL 34102 Phone: 786-734-0684 |